Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Validation of the 2025 Classification Criteria for Axial Spondyloarthritis

NCT07724847 is registered in ClinicalTrials.gov with Chinese PLA General Hospital as lead sponsor.

NCT NCT07724847
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07724847 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Validation of the 2025 Classification Criteria for Axial Spondyloarthritis
Lead sponsor
Chinese PLA General Hospital
Phase
Observational
Overall status
Recruiting
Start date
April 10, 2026
Completion date
April 10, 2027
Enrollment
247 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

axial spondyloarthritis (axspa), chronic back pain, spondyloarthritis (spa)